United States · FDA National Drug Code directory

Duloxetine Delayed-Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-8362_19b034a2-26d7-4c9b-b8a6-391e06a31adb
Product NDC
68788-8362
Form
CAPSULE, DELAYED RELEASE PELLETS
Composition / generic term
DULOXETINE HYDROCHLORIDE
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20230201
Source listing expiry
20261231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-0) · 68788-8362-0
  • 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-3) · 68788-8362-3
  • 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-9) · 68788-8362-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Duloxetine Delayed-Release — United States | Molindra Medicines